Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-054901

Director sold 5,000 shares at an average $177.48 ($887,411)

From the SEC's structured data for this filing

Trades in this filing

STUELPNAGEL JOHN R · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-01 Sale : show line 1 in the form −300 $175.36 $52,607 381,316 D
2021-09-01 Sale : show line 2 in the form −1,000 $176.36 $176,356 380,316 D
2021-09-01 Sale : show line 3 in the form −2,300 $177.62 $408,535 378,016 D
2021-09-01 Sale : show line 4 in the form −1,104 $178.34 $196,884 376,912 D
2021-09-01 Sale : show line 5 in the form −296 $179.15 $53,030 376,616 D
Open-market sales · 5,000 sh · avg $177.48 · $887,411
Loading xslF345X03/doc4.xml…